anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Paragraph

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 118,471
Current window 58,051-58,080
Pages 3,950
Rows per page 30
Component: Paragraphclear collectionreset all
18 30 60

Component

58,051-58,080 of 118,471

filter-aware
46
The slide outlines a weighted scoring system for Community Reinvestment Act (CRA) evaluations.2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research 1 hit
47
2022 strategic update presentation2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research 1 hit
51
2022 strategic update presentation2022 strategic update presentation · Goldman Sachs
Consulting deck Equity research 1 hit
01
Slide 1
2023.05.31 Bernstein Conference2023.05.31 Bernstein Conference · Morgan Stanley
Consulting deck Equity research 1 hit
07
The slide uses a simple three-column layout to present high-level strategic targets.2023.05.31 Bernstein Conference · Morgan Stanley
Consulting deck Equity research 1 hit
09
The chart uses a waterfall structure to bridge the gap between current and future assets.2023.05.31 Bernstein Conference · Morgan Stanley
Consulting deck Equity research 1 hit
12
This slide provides technical definitions for terms like WM Client Assets, Fee-Based Assets, Client Relationships, NNA, and peer comparison methodology.2023.05.31 Bernstein Conference · Morgan Stanley
Consulting deck Equity research 1 hit
14
2023.05.31 Bernstein Conference2023.05.31 Bernstein Conference · Morgan Stanley
Consulting deck Equity research 1 hit
152
This is a standard regulatory disclosure page defining key terminology.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
153
This is a standard regulatory disclosure page (glossary) from a Form ADV filing.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
154
This is a standard regulatory disclosure page defining key terminology.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
156
This is a regulatory disclosure document (Form ADV) containing specific fee tiers, minimum annual fees, and tracking error assumptions.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
157
This is a regulatory disclosure document (Form ADV) listing tiered fee structures based on assets under management.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
158
Page 158 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
162
Page 162 of a Form ADV document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
168
Part of a Form ADV disclosure document.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
173
This appears to be a page from a regulatory filing (Form ADV).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
174
This is a standard regulatory brochure supplement (Form ADV Part 2B).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
175
Standard regulatory disclosure document (Form ADV Part 2B).asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
179
This is a standard GLBA (Gramm-Leach-Bliley Act) privacy notice format.asset and wealth management mn · Goldman Sachs
Consulting deck Equity research 1 hit
07
The slide emphasizes the bioerodible nature and small size of the insert compared to legacy technology.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
10
Eyepoint Goldman Sachs June 10 2025Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
20
The outlier patient missed multiple visits, leading to significant vision loss at week 24.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
22
Includes company logo and copyright/disclaimer footer.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
23
Supplement-free is defined as patients who did not receive a supplement at any point during the study.Eyepoint Goldman Sachs June 10 2025 · EyePoint Pharmaceuticals
Consulting deck Equity research 1 hit
01
Slide 1
Goldman Sachs Presentation FinalGoldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Attention1 hit
06
Goldman Sachs Presentation FinalGoldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit
07
Includes data tables for volume composition and line charts for monthly sales volume growth relative to 2019.Goldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit
09
Includes two pie charts for relationship segmentation and a bar chart for talech customer growth.Goldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit
12
Includes pro-forma financial charts comparing USB standalone vs combined entity, and a table of branch footprints.Goldman Sachs Presentation Final · U.S. Bancorp
Consulting deck Equity research Beat · Satisfaction1 hit